SIGNAL  

Understanding and globalising drug safety is hard. We simplify the complex.

​

Signal helps biotech innovators overcome the challenges of drug safety, ensuring that promising therapies reach patients while meeting the highest regulatory standards.

Our mission is to transform pharmacovigilance from a compliance necessity into a strategic growth driver.

Signal provides tailored drug safety advice and strategic guidance that supports biotech companies through every phase to comply with pharmacovigilance regulations from clinical trials to market launch and beyond. We focus on creating scalable, agile systems that allow our clients to retain oversight while outsourcing day-to-day operations efficiently.

With decades of expertise in biotech regulatory environments, we help clients streamline pharmacovigilance processes, select the right partners, and maintain compliance across global markets. Our client-centric approach ensures that we adapt to each biotech’s unique needs, enabling them to focus on innovation and growth. Founded by industry experts, Signal is proud to be a female-led company with our team in London, Cambridge, Dublin, and Montreal.

As champions of the four-day workweek, we prioritize work-life balance while driving excellence and innovation. Our global presence enables us to serve clients across key markets with flexibility and responsiveness.